Meeting
2016 ASCO Annual Meeting
Performance of a 31-gene expression profile in a previously unreported cohort of 334 cutaneous melanoma patients.
Authors
Jonathan S. Zager
Moffitt Cancer Center, Tampa, FL
Jonathan S. Zager , Jane Messina , Vernon K. Sondak , Laura Ferris , Robert W. Cook , Brooke Middlebrook , Clare Johnson , Derek Maetzold , Federico A. Monzon , Jeffrey D. Wayne , Pedram Gerami
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Biologic Correlates
Citation
J Clin Oncol 34, 2016 (suppl; abstr 9581)
DOI
10.1200/JCO.2016.34.15_suppl.9581
Abstract #
9581
Poster Bd #
186
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Continued evaluation of a 31-gene expression profile test (GEP) for prediction of distant metastasis (DM) in cutaneous melanoma (CM).
First Author: David H. Lawson
Poster
2014 ASCO Annual Meeting
Gene expression profile test (GEP) prediction of metastasis-free (MFS) and overall survival (OS) in a cohort of cutaneous melanoma (CM) patients undergoing sentinel lymph node biopsy (SLNB).
First Author: David H. Lawson
Poster
2017 ASCO Annual Meeting
Performance of a 31-gene expression profile (GEP) test for metastatic risk prediction in cutaneous melanomas (CM) of the head and neck.
First Author: John T. Vetto
Poster
2022 ASCO Annual Meeting
Individualized prediction of distant metastases risk in oral cavity carcinoma: A validated predictive-score model.
First Author: Badr Id Said